In the print February issue of the BJGP, the article Moore M, et al. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups. Br J Gen Pract 2014; DOI: 10.3399/bjgp14X677121, the Results section was incorrectly published. We apologise for this error. This impacts significantly on the originally published article and only the online version of the article should be cited. Further to this, subsequent changes to the Results and Discussion sections were requested by the author and the corrected version is now available online. Correct Results for the print issue are as follows:
“Of the 2061 participants 595 (28%) were aged ≥60 years and 310 (15%) had chronic lung disease (asthma or COPD). Groups were well balanced at baseline. Subgroup analysis for the three outcomes identified the following:
No pre-specified subgroup was significantly more likely to benefit from antibiotic treatment in terms of symptoms rated moderately bad or worse. The result was of borderline significance for those with green sputum and there was modest impact on the median or interquartile range of symptom duration.
Those with comorbidities (lung disease, heart disease, diabetes, or prior hospital admission) experienced a significantly greater reduction in symptom severity between days 2–4 (Interaction term −0.28 P = 0.003; estimated effect of antibiotics −0.28 (95% CI = −0.44 to −0.11) P = 0.001) (Table 1).
No subgroup was significantly more likely to develop new or worsening symptoms.”
An additional sentence has been added to the penultimate paragraph of the Discussion:
“There was some evidence of modest benefit in non-smokers and those with shorter prior duration of illness although neither group was pre-specified.”
The online version is correct and can be accessed at: http://bjgp.org/content/64/619/e75.full